Pharma companies are now reluctantly agreeing to participate in the Center for Medicare and Medicaid Services’ first round of negotiations for 10 drugs.
Ahead of a key Oct. 1 deadline, both Bristol Myers Squibb and AstraZeneca have now said they will participate in the negotiations with CMS, although nearly all…
Click here to view original post
